Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis
{{output}}
Background: Hematopoietic stem cell transplant (HSCT) recipients are at increased risk of mortality and morbidity with coronavirus disease 2019 (COVID-19) due to severe immune dysfunction. ... ...
